AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28599016 — intervention group
Group type: COMPARATOR
Intervention: General Fitness Training (GFT)
Number of subjects: 23
Study 25952547 — intervention group
Group type: EXPERIMENTAL
Intervention: Hatha yoga intervention (8-week, twice-weekly)
Number of subjects: 52
Study 25952547 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 52
Study 23374364 — intervention group
Group type: EXPERIMENTAL
Intervention: PES (previous ERCP with ES)
Number of subjects: 176
Study 23374364 — intervention group
Group type: COMPARATOR
Intervention: NPES (no previous intervention)
Number of subjects: 176
Study 21340026 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib therapy
Number of subjects: 0
Study 21340026 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 19326174 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg diazepam, given orally 1 hour before 18F-FDG injection
Number of subjects: 52
Study 19326174 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 17595888 — intervention group
Group type: EXPERIMENTAL
Intervention: RNF1
Number of subjects: 48
Study 17595888 — intervention group
Group type: EXPERIMENTAL
Intervention: RNF2
Number of subjects: 48
Study 17595888 — intervention group
Group type: EXPERIMENTAL
Intervention: R (current formulation)
Number of subjects: 48
Study 17595888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 12617708 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta carotene (50 mg on alternate days)
Number of subjects: 22071
Study 12617708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22071
Study 10678541 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg/day)
Number of subjects: 12
Study 10678541 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol (10 mg/day)
Number of subjects: 12
Study 10678541 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 9164806 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard BP measurement protocol (ensuring restful state, proper positioning, and quiet time)
Number of subjects: 64
Study 9164806 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard BP measurement protocol
Number of subjects: 64
Study 9164806 — intervention group
Group type: COMPARATOR
Intervention: Routine nurse measurements
Number of subjects: 64
Study 8455331 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpodoxime (CPDX-PR) given orally twice a day at 100-200 mg for 5-21 days
Number of subjects: 61
Study 3764230 — intervention group
Group type: EXPERIMENTAL
Intervention: Test handwashing protocol
Number of subjects: 0
Study 3764230 — intervention group
Group type: COMPARATOR
Intervention: Standard handwashing protocol
Number of subjects: 0
Study 31732867 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative meloxicam administration
Number of subjects: 196
Study 31732867 — intervention group
Group type: COMPARATOR
Intervention: Post-operative meloxicam administration
Number of subjects: 196
Study 30754668 — intervention group
Group type: EXPERIMENTAL
Intervention: HY-coated implants
Number of subjects: 106
Study 30754668 — intervention group
Group type: COMPARATOR
Intervention: Control implants
Number of subjects: 106
Study 30103509 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher Protein Diet (HP)
Number of subjects: 54
Study 30103509 — intervention group
Group type: COMPARATOR
Intervention: Higher Carbohydrate Diet (HC)
Number of subjects: 54
Study 30103509 — intervention group
Group type: COMPARATOR
Intervention: Exercise-only group (E)
Number of subjects: 54
Study 26486682 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative exercise program
Number of subjects: 69
Study 26486682 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 69
Study 24684867 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic surgery (SILS)
Number of subjects: 75
Study 24684867 — intervention group
Group type: COMPARATOR
Intervention: 3-port laparoscopic surgery
Number of subjects: 75
Study 24684867 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 75
Study 21765343 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week educational program on memory training, physical activity, stress reduction, and healthy diet
Number of subjects: 115
Study 19631843 — intervention group
Group type: EXPERIMENTAL
Intervention: Endodontic surgical procedures
Number of subjects: 0
Study 17956196 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 0
Study 17956196 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 0
Study 17956196 — intervention group
Group type: COMPARATOR
Intervention: Raloxifene
Number of subjects: 0
Study 17956196 — intervention group
Group type: COMPARATOR
Intervention: Ibandronate
Number of subjects: 0
Study 17956196 — intervention group
Group type: COMPARATOR
Intervention: Strontium
Number of subjects: 0
Study 17956196 — intervention group
Group type: COMPARATOR
Intervention: Parathyroid hormone
Number of subjects: 0
Study 17956196 — intervention group
Group type: COMPARATOR
Intervention: Ibandronate (intermittent intravenous administration)
Number of subjects: 0
Study 17956196 — intervention group
Group type: COMPARATOR
Intervention: Zoledronate (intermittent intravenous administration)
Number of subjects: 0
Study 17956196 — intervention group
Group type: COMPARATOR
Intervention: Denosumab (subcutaneous administration)
Number of subjects: 0
Study 15259827 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief educational and advice support service
Number of subjects: 106
Study 15259827 — intervention group
Group type: COMPARATOR
Intervention: Usual care from community psychiatric services
Number of subjects: 106
Study 12454533 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 10567777 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone plus aminoglycoside with filgrastim (once daily for > or =5 days, > or =2 days, and until ANC > or =1.0x10(9)/l for 2 days)
Number of subjects: 105
Study 10567777 — intervention group
Group type: COMPARATOR
Intervention: Out-patient treatment (early discharge)
Number of subjects: 105
Study 7600120 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant hirudin (HBW 023, 0.35 mg/kg body wt SC)
Number of subjects: 15
Study 7600120 — intervention group
Group type: COMPARATOR
Intervention: unfractionated heparin (UFH, HeparinNovo; 150 IU/kg body wt SC)
Number of subjects: 15
Study 7600120 — intervention group
Group type: COMPARATOR
Intervention: low-molecular-weight heparin (LMWH, Fragmin; 75 IU/kg body wt SC)
Number of subjects: 15
Study 2204661 — intervention group
Group type: EXPERIMENTAL
Intervention: Branched-chain amino acids (0.24 g/kg)
Number of subjects: 64
Study 2204661 — intervention group
Group type: COMPARATOR
Intervention: Casein (equinitrogenous amount)
Number of subjects: 64
Study 678831 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg/kg oxamniquine
Number of subjects: 0
Study 678831 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/kg oxamniquine
Number of subjects: 0
Study 678831 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/kg oxamniquine
Number of subjects: 0
Study 30649485 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography (CT)‐based image‐guided brachytherapy (IGBT) with whole‐pelvic radiotherapy and concurrent chemotherapy (76% of patients)
Number of subjects: 84
Study 30649485 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography (CT)‐based image‐guided brachytherapy (IGBT)
Number of subjects: 84
Study 27377577 — intervention group
Group type: EXPERIMENTAL
Intervention: IMAGE intervention (Improving Mothers' parenting Abilities, Growth, and Effectiveness)
Number of subjects: 124
Study 27377577 — intervention group
Group type: COMPARATOR
Intervention: Standard care control condition
Number of subjects: 124
Study 26200143 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite (NaOCl)
Number of subjects: 62
Study 26200143 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine (CHX) gel
Number of subjects: 62
Study 23172172 — intervention group
Group type: EXPERIMENTAL
Intervention: PRT-201 (0.0033 to 9 mg)
Number of subjects: 66
Study 23172172 — intervention group
Group type: EXPERIMENTAL
Intervention: PRT-201 (Low Dose)
Number of subjects: 66
Study 23172172 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 21132439 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate state (CHO)
Number of subjects: 20
Study 21132439 — intervention group
Group type: COMPARATOR
Intervention: Fasted state (F)
Number of subjects: 20
Study 21132439 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (F and CHO)
Number of subjects: 20
Study 19709723 — intervention group
Group type: EXPERIMENTAL
Intervention: OC-PA (Organic Contamination with Phosphoric Acid cleaning)
Number of subjects: 100
Study 19709723 — intervention group
Group type: EXPERIMENTAL
Intervention: IC-FU (Inorganic Contamination with Furnace cleaning)
Number of subjects: 100
Study 19709723 — intervention group
Group type: EXPERIMENTAL
Intervention: OC+IC-PA+FU (Organic and Inorganic Contamination with both cleaning methods)
Number of subjects: 100
Study 19709723 — intervention group
Group type: EXPERIMENTAL
Intervention: OC+IC-no cleaning (Organic and Inorganic Contamination with no cleaning)
Number of subjects: 100
Study 19709723 — intervention group
Group type: COMPARATOR
Intervention: no contamination-no cleaning (Control group)
Number of subjects: 100
Study 17286730 — intervention group
Group type: EXPERIMENTAL
Intervention: Community hospital care
Number of subjects: 13
Study 15534121 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 225
Study 15534121 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 225
Study 15534121 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (subgroup with visual acuity worse than 20/100)
Number of subjects: 225
Study 11292293 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) combined with cyclosporin (CyA) and steroids (Pred)
Number of subjects: 65
Study 11292293 — intervention group
Group type: COMPARATOR
Intervention: Historic azathioprine (AZA) group (CyA, Pred, and azathioprine)
Number of subjects: 65
Study 9480238 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpregnant women with RSA
Number of subjects: 117
Study 9480238 — intervention group
Group type: COMPARATOR
Intervention: Healthy nonpregnant multigravidas (control)
Number of subjects: 117
Study 7894531 — intervention group
Group type: EXPERIMENTAL
Intervention: Ointment containing 2-chloroethyl-3-chloropropyl sulfide (CLEPS) applied topically
Number of subjects: 0
Study 7894531 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal control)
Number of subjects: 0
Study 6146346 — intervention group
Group type: EXPERIMENTAL
Intervention: Astemizole, 10 mg
Number of subjects: 63
Study 6146346 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 30639252 — intervention group
Group type: EXPERIMENTAL
Intervention: WP pre‐RT
Number of subjects: 70
Study 30639252 — intervention group
Group type: EXPERIMENTAL
Intervention: WP post‐RT
Number of subjects: 70
Study 30639252 — intervention group
Group type: COMPARATOR
Intervention: PLA pre and post‐RT
Number of subjects: 70
Study 30158068 — intervention group
Group type: EXPERIMENTAL
Intervention: On-pump CABG
Number of subjects: 100
Study 30158068 — intervention group
Group type: COMPARATOR
Intervention: Off-pump CABG
Number of subjects: 100
Study 25162653 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory-loaded core training (ICT)
Number of subjects: 16
Study 25162653 — intervention group
Group type: COMPARATOR
Intervention: Control condition (CON)
Number of subjects: 16
Study 25006718 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 750
Study 25006718 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene
Number of subjects: 750
Study 22113536 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold environment (7°C)
Number of subjects: 9
Study 22113536 — intervention group
Group type: EXPERIMENTAL
Intervention: Room temperature (20°C)
Number of subjects: 9
Study 22113536 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot environment (33°C)
Number of subjects: 9
Study 22113536 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (1 h cycling at 60% Wmax)
Number of subjects: 9
Study 20395821 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal ketorolac (2.0 mg)
Number of subjects: 41
Study 20395821 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ketorolac
Number of subjects: 41
Study 17425549 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrofiber Ag dressing
Number of subjects: 67
Study 17425549 — intervention group
Group type: COMPARATOR
Intervention: povidone-iodine gauze
Number of subjects: 67
Study 17092241 — intervention group
Group type: EXPERIMENTAL
Intervention: Emdogain alone
Number of subjects: 56
Study 17092241 — intervention group
Group type: EXPERIMENTAL
Intervention: Emdogain + beta-TCP
Number of subjects: 56
Study 17092241 — intervention group
Group type: COMPARATOR
Intervention: Modified Widman flap (MWF)
Number of subjects: 56
Study 15243302 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous treprostinil sodium (10 ng/kg/min for 72 hours)
Number of subjects: 51
Study 15243302 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous treprostinil sodium (10 ng/kg/min for 72 hours)
Number of subjects: 51
Study 15243302 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous treprostinil sodium
Number of subjects: 51
Study 15243302 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous treprostinil sodium
Number of subjects: 51
Study 11341175 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal serum natural antibodies (N‐Ab) of IgG class to proteins MBP, S100, ACBP14/18 and MP65
Number of subjects: 1987
Study 11341175 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormally high and low reactivity of maternal N‐Ab
Number of subjects: 1987
Study 8861797 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine after cessation of CsA
Number of subjects: 12
Study 8861797 — intervention group
Group type: COMPARATOR
Intervention: CsA continued (Control)
Number of subjects: 12
Study 1386977 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron injection (4 mg once daily by intravenous administration for 3-5 consecutive days)
Number of subjects: 207
Study 1386977 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron injection
Number of subjects: 207
Study 6370637 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol maleate 0.50% (short-term trial)
Number of subjects: 30
Study 6370637 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol maleate 0.50% or 0.25% (long-term trial)
Number of subjects: 30
Study 30813758 — intervention group
Group type: EXPERIMENTAL
Intervention: CTO-PCI
Number of subjects: 834
Study 30813758 — intervention group
Group type: COMPARATOR
Intervention: No CTO-PCI
Number of subjects: 834
Study 28267236 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/day vonoprazan for 8 weeks
Number of subjects: 92
Study 25950747 — intervention group
Group type: EXPERIMENTAL
Intervention: Left-lateralised children
Number of subjects: 58
Study 25950747 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater variability in lateralised response
Number of subjects: 58
Study 25950747 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed establishment of language specialisation
Number of subjects: 58
Study 25950747 — intervention group
Group type: COMPARATOR
Intervention: Right- and bi-lateralised children
Number of subjects: 58
Study 24053577 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture treatment two times per week for 4 weeks
Number of subjects: 60
Study 24053577 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no acupuncture treatment)
Number of subjects: 60
Study 24053577 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture treatment
Number of subjects: 60
Study 21427394 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised intake of artemether-lumefantrine
Number of subjects: 359
Study 21427394 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised intake of artemether-lumefantrine
Number of subjects: 359
Study 21427394 — intervention group
Group type: EXPERIMENTAL
Intervention: Both supervised and unsupervised intake of artemether-lumefantrine
Number of subjects: 359
Study 19266389 — intervention group
Group type: EXPERIMENTAL
Intervention: GPLC-1 (1g PLC/d)
Number of subjects: 32
Study 19266389 — intervention group
Group type: EXPERIMENTAL
Intervention: GPLC-3 (3g PLC/d)
Number of subjects: 32
Study 19266389 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 19266389 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 32
Study 19266389 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaerobic exercise
Number of subjects: 32
Study 16950986 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal indomethacin treatment
Number of subjects: 47
Study 16950986 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 47
Study 15471934 — intervention group
Group type: EXPERIMENTAL
Intervention: PGD‐AS (Preimplantation Genetic Diagnosis for Aneuploidy Screening)
Number of subjects: 400
Study 15471934 — intervention group
Group type: COMPARATOR
Intervention: Control group (without PGD‐AS)
Number of subjects: 400
Study 15471934 — intervention group
Group type: EXPERIMENTAL
Intervention: PGD‐AS
Number of subjects: 400
Study 15471934 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 400
Study 11748505 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (P1 and P4)
Number of subjects: 69
Study 11748505 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training (P2 and P5)
Number of subjects: 69
Study 11748505 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of aerobic and strength training (P4 and P6)
Number of subjects: 69
Study 11748505 — intervention group
Group type: COMPARATOR
Intervention: Control group (P1 - P3 without supplemental oxygen)
Number of subjects: 69
Study 11748505 — intervention group
Group type: COMPARATOR
Intervention: Control group (P4 - P6 with supplemental oxygen)
Number of subjects: 69
Study 9250896 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunochemical fecal occult blood test
Number of subjects: 341
Study 7995681 — intervention group
Group type: EXPERIMENTAL
Intervention: GGGS treatment
Number of subjects: 0
Study 7995681 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3518342 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparotomy with splenectomy
Number of subjects: 69
Study 3518342 — intervention group
Group type: COMPARATOR
Intervention: Total nodal irradiation (excluding the splenic and hepatic areas)
Number of subjects: 69
Study 3518342 — intervention group
Group type: EXPERIMENTAL
Intervention: Splenectomized patients with splenic tumour involvement
Number of subjects: 69
Study 28961020 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol (FF/VI) 100/25 µg
Number of subjects: 1504
Study 28961020 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol (FP/SAL) 250/50 µg
Number of subjects: 1504
Study 28961020 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 250 µg
Number of subjects: 1504
Study 27777438 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect bonding technique
Number of subjects: 100
Study 27777438 — intervention group
Group type: COMPARATOR
Intervention: Direct bonding technique
Number of subjects: 100
Study 21767927 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Disease Self-Management Programme (CDSMP)
Number of subjects: 629
Study 21767927 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 629
Study 20133502 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 20133502 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus an information program
Number of subjects: 0
Study 20133502 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus a decision analysis program
Number of subjects: 0
Study 17764779 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 35mg/m(2) IV on days 1 and 8 plus daily oral UFUR 150mg/m(2) of every 3 weeks (arm DU)
Number of subjects: 48
Study 17764779 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel 40mg/m(2) IV on days 1 and 8 of every 3 weeks (arm D)
Number of subjects: 48
Study 15673894 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-chloroprocaine with clonidine (15 microg)
Number of subjects: 8
Study 15673894 — intervention group
Group type: COMPARATOR
Intervention: 2-chloroprocaine (30 mg)
Number of subjects: 8
Study 11755289 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose enalapril (40 mg/day)
Number of subjects: 75
Study 11755289 — intervention group
Group type: COMPARATOR
Intervention: Low-dose enalapril (5 mg/day)
Number of subjects: 75
Study 10347965 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper Limb Training (UL)
Number of subjects: 28
Study 10347965 — intervention group
Group type: COMPARATOR
Intervention: Lower Limb Training (LL)
Number of subjects: 28
Study 10347965 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (LL and UL)
Number of subjects: 28
Study 7647181 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted approach including performance-based measures, cognitive tests, and physiological assessments
Number of subjects: 0
Study 7647181 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological assessments
Number of subjects: 0
Study 7647181 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-based measures
Number of subjects: 0
Study 2788406 — intervention group
Group type: EXPERIMENTAL
Intervention: Ostoprin (4.0 g per day)
Number of subjects: 40
Study 2788406 — intervention group
Group type: COMPARATOR
Intervention: Ecotrin (3.9 g per day)
Number of subjects: 40
Study 2788406 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Ostoprin and Ecotrin
Number of subjects: 40
Study 15901 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovral
Number of subjects: 480
Study 15901 — intervention group
Group type: EXPERIMENTAL
Intervention: Norinyl 1/50
Number of subjects: 480
Study 15901 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortestrin 1
Number of subjects: 480
Study 30666100 — intervention group
Group type: EXPERIMENTAL
Intervention: IND/GLY 110/50 µg once daily
Number of subjects: 38